当前位置: X-MOL 学术Environ. Toxicol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling
Environmental Toxicology ( IF 4.4 ) Pub Date : 2021-05-11 , DOI: 10.1002/tox.23160
Bugao Guan 1 , Jun Ma 1 , Zhi Yang 2 , Fei Yu 1 , Jian Yao 2
Affiliation  

Long noncoding RNAs (lncRNAs) exert crucial effects on the development of many malignancies, including gastric cancer. Herein, we investigated the role of lncRNA noncatalytic region of tyrosine kinase adaptor protein 1 (NCK1) divergent transcript (NCK1-DT, also known as NCK1-AS1) in gastric cancer. Reverse transcription quantitative polymerase chain reaction demonstrated that NCK1-AS1 exhibited high expression in gastric cancer tissues and cells. In vitro assays including MTT, colony formation, Transwell, wound healing and sphere formation assays indicated that NCK1-AS1 depletion inhibited cell proliferation, migration, invasion and stemness maintenance. Luciferase reporter and RIP assays suggested that NCK1-AS1 functioned as a competitive endogenous RNA (ceRNA) for miR-22-3p to positively modulate BCL9 expression. BCL9 was a target gene of miR-22-3p. According to western blot analysis and TOP/FOP flash assay, NCK1-AS1 activated the Wnt/β-catenin signaling via the miR-22-3p/BCL9 axis. Furthermore, rescue experiments verified that NCK1-AS1 affected cellular processes by activating the Wnt/β-catenin signaling pathway via the miR-22-3p/BCL9 axis. Tumor xenograft model validated that NCK1-AS1 promoted tumor growth in vivo via the Wnt/β-catenin signaling by upregulating BCL9 expression. Overall, NCK1-AS1 functions as an oncogene and promotes gastric cancer progression via the miR-22-3p/BCL9-Wnt/β-catenin signaling pathway.

中文翻译:

LncRNA NCK1-AS1 通过靶向 miR-22-3p/BCL9 轴激活 Wnt/β-catenin 信号通路在胃癌中发挥致癌作用

长链非编码 RNA (lncRNA) 对包括胃癌在内的许多恶性肿瘤的发展发挥着至关重要的作用。在此,我们研究了酪氨酸激酶衔接蛋白 1 (NCK1) 不同转录本 (NCK1-DT,也称为 NCK1-AS1) 的 lncRNA 非催化区在胃癌中的作用。逆转录定量聚合酶链反应表明NCK1-AS1在胃癌组织和细胞中高表达。包括 MTT、集落形成、Transwell、伤口愈合和球体形成测定在内的体外测定表明,NCK1-AS1 消耗抑制细胞增殖、迁移、侵袭和干性维持。荧光素酶报告基因和 RIP 分析表明 NCK1-AS1 作为 miR-22-3p 的竞争性内源性 RNA (ceRNA) 发挥正向调节 BCL9 表达的作用。BCL9 是 miR-22-3p 的靶基因。根据蛋白质印迹分析和 TOP/FOP 闪存分析,NCK1-AS1 通过 miR-22-3p/BCL9 轴激活 Wnt/β-catenin 信号。此外,救援实验证实 NCK1-AS1 通过 miR-22-3p/BCL9 轴激活 Wnt/β-catenin 信号通路影响细胞过程。肿瘤异种移植模型验证 NCK1-AS1 通过上调 BCL9 表达通过 Wnt/β-catenin 信号传导促进体内肿瘤生长。总体而言,NCK1-AS1 作为癌基因发挥作用,通过 miR-22-3p/BCL9-Wnt/β-catenin 信号通路促进胃癌进展。救援实验证实 NCK1-AS1 通过 miR-22-3p/BCL9 轴激活 Wnt/β-catenin 信号通路影响细胞过程。肿瘤异种移植模型验证 NCK1-AS1 通过上调 BCL9 表达通过 Wnt/β-catenin 信号传导促进体内肿瘤生长。总体而言,NCK1-AS1 作为癌基因发挥作用,通过 miR-22-3p/BCL9-Wnt/β-catenin 信号通路促进胃癌进展。救援实验证实 NCK1-AS1 通过 miR-22-3p/BCL9 轴激活 Wnt/β-catenin 信号通路影响细胞过程。肿瘤异种移植模型验证 NCK1-AS1 通过上调 BCL9 表达通过 Wnt/β-catenin 信号传导促进体内肿瘤生长。总体而言,NCK1-AS1 作为癌基因发挥作用,通过 miR-22-3p/BCL9-Wnt/β-catenin 信号通路促进胃癌进展。
更新日期:2021-07-02
down
wechat
bug